203 related articles for article (PubMed ID: 11529468)
21. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura U; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Tsubaki K; Saito K; Kuriyama K; Oh H; Kitano K; Miyawaki S; Takeyama U; Yamada O; Nishikawa K; Takahashi M; Matsuda S; Ohtake H; Ohno R
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370
[TBL] [Abstract][Full Text] [Related]
22. Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.
Fisher BT; Singh S; Huang YS; Li Y; Gregory J; Walker D; Seif AE; Kavcic M; Aplenc R
Pediatr Blood Cancer; 2014 Jan; 61(1):68-73. PubMed ID: 23868668
[TBL] [Abstract][Full Text] [Related]
23. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
[TBL] [Abstract][Full Text] [Related]
24. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
25. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid in acute promyelocytic leukaemia.
Avvisati G; Tallman MS
Best Pract Res Clin Haematol; 2003 Sep; 16(3):419-32. PubMed ID: 12935960
[TBL] [Abstract][Full Text] [Related]
27. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
29. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
Tsimberidou AM; Tirado-Gomez M; Andreeff M; O'Brien S; Kantarjian H; Keating M; Lopez-Berestein G; Estey E
Leuk Lymphoma; 2006 Jun; 47(6):1062-8. PubMed ID: 16840198
[TBL] [Abstract][Full Text] [Related]
30. Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment.
Raanani P; Segal E; Levi I; Bercowicz M; Berkenstat H; Avigdor A; Perel A; Ben-Bassat I
Leuk Lymphoma; 2000 May; 37(5-6):605-10. PubMed ID: 11042521
[TBL] [Abstract][Full Text] [Related]
31. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare.
Ohno R; Yoshida H; Fukutani H; Naoe T; Ohshima T; Kyo T; Endoh N; Fujimoto T; Kobayashi T; Hiraoka A
Leukemia; 1993 Nov; 7(11):1722-7. PubMed ID: 8231241
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
33. Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy.
Thomas X; Anglaret B; Thiebaut A; Belhabri A; Treille-Ritouet D; Fiere D; Archimbaud E
Ann Hematol; 1997; 75(5-6):195-200. PubMed ID: 9433375
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
Sun GL
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia.
Seiter K; Miller WH; Feldman EJ; Ahmed T; Arlin Z
Leukemia; 1995 Jan; 9(1):15-8. PubMed ID: 7845010
[TBL] [Abstract][Full Text] [Related]
36. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.
Di Bona E; Avvisati G; Castaman G; Luce Vegna M; De Sanctis V; Rodeghiero F; Mandelli F
Br J Haematol; 2000 Mar; 108(4):689-95. PubMed ID: 10792270
[TBL] [Abstract][Full Text] [Related]
37. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
38. Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Cicconi L; Breccia M; Franceschini L; Latagliata R; Molica M; Divona M; Diverio D; Rizzo M; Ottone T; Iaccarino L; Alfonso V; Foa R; Voso MT; Lo-Coco F
Ann Hematol; 2018 Oct; 97(10):1797-1802. PubMed ID: 29951912
[TBL] [Abstract][Full Text] [Related]
39. [Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid].
Tajima K; Sagae M; Yahagi A; Akiba J; Suzuki K; Hayashi T; Satoh S
Rinsho Ketsueki; 1998 Jan; 39(1):48-52. PubMed ID: 9492553
[TBL] [Abstract][Full Text] [Related]
40. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]